Idexx Laboratories (IDXX) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $573.7 million.
- Idexx Laboratories' Total Non-Current Liabilities fell 2070.15% to $573.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $573.7 million, marking a year-over-year decrease of 2070.15%. This contributed to the annual value of $630.2 million for FY2024, which is 2350.36% down from last year.
- Idexx Laboratories' Total Non-Current Liabilities amounted to $573.7 million in Q3 2025, which was down 2070.15% from $648.1 million recorded in Q2 2025.
- Idexx Laboratories' Total Non-Current Liabilities' 5-year high stood at $1.0 billion during Q2 2021, with a 5-year trough of $573.7 million in Q3 2025.
- Over the past 5 years, Idexx Laboratories' median Total Non-Current Liabilities value was $893.1 million (recorded in 2023), while the average stood at $843.4 million.
- Per our database at Business Quant, Idexx Laboratories' Total Non-Current Liabilities surged by 765.48% in 2021 and then plummeted by 2395.1% in 2025.
- Quarter analysis of 5 years shows Idexx Laboratories' Total Non-Current Liabilities stood at $983.6 million in 2021, then decreased by 8.28% to $902.2 million in 2022, then dropped by 8.69% to $823.8 million in 2023, then decreased by 23.5% to $630.2 million in 2024, then fell by 8.97% to $573.7 million in 2025.
- Its Total Non-Current Liabilities was $573.7 million in Q3 2025, compared to $648.1 million in Q2 2025 and $629.5 million in Q1 2025.